about
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude miceCell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cellsConcurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAFCell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigensSerological survey of normal humans for natural antibody to cell surface antigens of melanomaGenetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.A comprehensive transcriptional portrait of human cancer cell lines.Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma.Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines.Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.Absence of HeLa cell contamination in 169 cell lines derived from human tumors.Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.Human tumor lines for cancer research.Production and characterization of antibodies against human tyrosinase.A pigmentation-associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serum.
P4510
Q27852894-C9D4631E-49F8-4053-A4F7-3314E24E8D89Q28294341-FBC1C1CE-88CA-48ED-80B7-B4982F3280D4Q35025264-CAFEB89F-5BA1-4760-8D56-80E269E93DE0Q35700459-4DF8E2D9-E877-404F-8C53-D358E6CC9A09Q36247943-4B1A6F86-EC54-4CCC-9B28-FB005814F398Q36347214-431B203F-CCFE-4D0D-8123-830E624176C1Q36359942-F177061E-CB5D-480F-A404-B1BCD7BF9253Q36399013-083B0C47-50A5-4866-867D-D90057B14694Q36982042-3487831A-3628-4CF6-81F5-F0FD0A87E609Q37854720-91FACAAC-48A5-4985-A4B1-4B0DA7EEFEE5Q40169723-992F22E8-CE0E-41A0-9291-0BE44BD836C5Q40507438-9C922117-541A-4E88-B438-CD0B92D1B02AQ40887108-8321FC3B-BB1E-4823-A037-EF8D4463B18AQ41761715-39A12D66-2CB7-4D32-96A9-0B42453B7429Q42799579-079E5A1E-7A2A-4422-A6AA-475B6C2B6A3AQ42818580-86631D60-A602-45BB-8BED-1909222CADC7Q52826141-DD74C4B0-973C-4E80-A97F-6294E50D687CQ52834169-29363595-9536-43B2-AB87-1201B8C3DFEEQ52834172-0289C04F-EB25-4EA5-9601-C319D30DE9F4
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
SK-MEL-23
@de
SK-MEL-23
@en
SK-MEL-23
@fr
SK-MEL-23
@ga
SK-MEL-23
@nl
type
label
SK-MEL-23
@de
SK-MEL-23
@en
SK-MEL-23
@fr
SK-MEL-23
@ga
SK-MEL-23
@nl
altLabel
AP-Mel
@en
SK MEL 23
@en
SK-Mel 23
@en
SK-Mel-23
@en
SK23
@en
SK23-MEL
@en
SKMEL-23
@en
SKMEL23
@en
Sk Mel23
@en
prefLabel
SK-MEL-23
@de
SK-MEL-23
@en
SK-MEL-23
@fr
SK-MEL-23
@ga
SK-MEL-23
@nl